Tumor necrosis factor inhibitors in patients with Takayasu arteritis: Experience from a referral center with long‐term followup

In this study, treatment with TNF inhibitors induced remission, including sustained remission in patients with refractory TA. However, 33% of patients experienced disease relapse while receiving TNF inhibitors and 20% discontinued treatment because of adverse events.